Latest Trials Latest NewsFAQ

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Tau PET Imaging in Atypical Dementias

Phase 1

Active, not recruiting

Conditions: Primary Progressive Aphasia With Suspected Alzheimer's Disease

Interventions: Drug: 18F-AV-1451
Device: PET

First Posted Date: 2017-09-14

Last Posted Date: 2024-10-16

Lead Sponsor: University of Chicago

Target Recruit Count: 70

Registration Number: NCT03283449

Locations: 🇺🇸
University of Chicago - American School Building, Chicago, Illinois, United States

Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL

Phase 1

Active, not recruiting

Conditions: CLL
B-cell Non Hodgkin Lymphoma

Interventions: Drug: TGR-1202
Drug: Pembrolizumab

First Posted Date: 2017-09-14

Last Posted Date: 2024-01-29

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT03283137

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling

Not Applicable

Conditions: Kidney Stone

Interventions: Dietary Supplement: Sodium and Potassium Citrate
Dietary Supplement: Placebo

First Posted Date: 2017-09-13

Last Posted Date: 2021-10-11

Lead Sponsor: University of Chicago

Target Recruit Count: 52

Registration Number: NCT03281928

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Parkinson's Disease in African American and Caucasian Patients

Completed

Conditions: Parkinson Disease

First Posted Date: 2017-09-12

Last Posted Date: 2023-05-08

Lead Sponsor: University of Chicago

Target Recruit Count: 2033

Registration Number: NCT03279445

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Diet and Sleep Monitoring

Not Applicable

Completed

Conditions: Diet Modification
Sleep

Interventions: Other: Diet Quality

First Posted Date: 2017-08-22

Last Posted Date: 2022-11-22

Lead Sponsor: University of Chicago

Target Recruit Count: 5

Registration Number: NCT03257137

Locations: 🇺🇸
Univeristy of Chicago, Chicago, Illinois, United States

Trial Comparing Intrathecal Morphine With Placebo In Patients Undergoing Robotic Cardiac Surgery

Phase 4

Completed

Conditions: Pain

Interventions: Drug: Placebo
Drug: Intrathecal morphine

First Posted Date: 2017-08-07

Last Posted Date: 2021-11-23

Lead Sponsor: University of Chicago

Target Recruit Count: 79

Registration Number: NCT03241485

Locations: 🇺🇸
University of Chicago Hospital, Chicago, Illinois, United States

A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy

Phase 2

Withdrawn

Conditions: Head and Neck Cancer

Interventions: Drug: Pembrolizumab
Drug: epacadostat

First Posted Date: 2017-08-03

Last Posted Date: 2018-01-04

Lead Sponsor: University of Chicago

Registration Number: NCT03238638

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core Biopsy

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Other: Nature sounds

First Posted Date: 2017-08-03

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 200

Registration Number: NCT03238976

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Phase 2

Active, not recruiting

Conditions: Triple Negative Breast Neoplasms
Breast Cancer

Interventions: Drug: Pembrolizumab
Drug: Mifepristone

First Posted Date: 2017-07-21

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 74

Registration Number: NCT03225547

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Recruiting

Conditions: Information Seeking Behavior

First Posted Date: 2017-07-21

Last Posted Date: 2024-11-22

Lead Sponsor: University of Chicago

Target Recruit Count: 1000

Registration Number: NCT03225820

Locations: 🇺🇸
The University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy